• 595 Citations
  • 12 h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


  • Ph.D (Pharmacy), Taipei Medical University
  • 1986 M.S., (Pharmacy), Taipei Medical University
  • 1983 B.S., (Pharmacy), Taipei Medical University


  • 2017-2020 The Consultant of the Taipei Pharmacists Association(19th) 
  • 2012- Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
  • 1996-1997 Division Director, Curriculum Division, Taipei Medical University

Research Interests

  • The pharmacokinetics of drugs/TCMs and their interaction
  • Formulation and manufacture of pharmacosmetics
  • Potential natural products having hypoglycemic activity with insulin release/glucose uptake properties.
  • Pharmacophore modeling to design the potential enzyme Inhibitors (cooperated with NTUT lab)

Fingerprint Dive into the research topics where Yih Ho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Ho, Y.


Project: C - Project of Alliancei - National Taipei University of Technology

Structure-based virtual screening to discover potential inhibitors of CDP-ME kinase for treating tuberculosis

Ho, Y.


Project: C - Project of Alliancei - National Taipei University of Technology


Ho, Y.


Project: C - Project of Alliancei - National Taipei University of Technology

Research Output

  • 595 Citations
  • 12 h-Index
  • 55 Article
  • 2 Review article

Integrin αvβ3 in the mediating effects of dihydrotestosterone and resveratrol on breast cancer cell proliferation

Ho, Y., Zi-Lin, L., Ya-Jung, S., Yi-Ru, C., Wang, K., Whang-Peng, J., Hung-Yun, L. & Davis, P. J., Apr 2 2020, In : International Journal of Molecular Sciences. 21, 8, 2906.

Research output: Contribution to journalReview article

Open Access
  • NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells

    Ho, Y., Wu, C. Y., Chin, Y. T., Li, Z. L., Pan, Y. S., Huang, T. Y., Su, P. Y., Lee, S. Y., Crawford, D. R., Su, K. W., Chiu, H. C., Shih, Y. J., Changou, C. A., Yang, Y. C. S. H., Whang-Peng, J., Chen, Y. R., Lin, H. Y., Mousa, S. A., Davis, P. J. & Wang, K., Feb 1 2020, In : Food and Chemical Toxicology. 136, p. 111092 111092.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Discovery of Novel Irreversible HER2 Inhibitors for Breast Cancer Treatment

    Tang, J. Y., Ho, Y., Chang, C. Y. & Liu, H. L., Apr 2019, In : Journal of Biomedical Science and Engineering.

    Research output: Contribution to journalArticle

    Leptin-derived peptides block leptin-induced proliferation by reducing expression of pro-inflammatory genes in hepatocellular carcinoma cells

    Ho, Y., Wang, S. H., Chen, Y. R., Li, Z. L., Chin, Y. T., Yang, Y. C. S. H., Wu, Y. H., Su, K. W., Chu, H. R., Chiu, H. C., Crawford, D. R., Shih, Y. J., Grasso, P., Tang, H. Y., Lin, H. Y., Davis, P. J., Whang-Peng, J. & Wang, K., Nov 1 2019, In : Food and Chemical Toxicology. 133, p. 110808 110808.

    Research output: Contribution to journalArticle